Please provide your email address to receive an email when new articles are posted on . “There is often more awareness and concern about cancer as a result of smoking than heart disease, so we wanted ...
SAINT PAUL, Minn.--(BUSINESS WIRE)--Aria CV, Inc, a developer of medical devices treating pulmonary hypertension, today announced the first patient was implanted with the Gen 2 Aria CV Pulmonary ...
We prepare our consolidated financial statements in accordance with generally accepted accounting principles for the United States (GAAP). The non-GAAP financial measures, such as net income (loss) ...
Please provide your email address to receive an email when new articles are posted on . Evolocumab is the first PCSK9 inhibitor to demonstrate effectiveness in primary and secondary prevention ...
In patients with type 2 diabetes (T2D) without prior cardiovascular disease (CVD), heart failure (HF) accounted for 16.8% of first major CV events. The occurrence of HF was more strongly associated ...
With the eyes of the military firmly fixed on other tiltrotor aircraft currently being developed, one would have thought the existing V-22 Osprey is kind of on its way out the door. But that’s hardly ...
SAN DIEGO, May 9, 2023 /PRNewswire/ -- CV Sciences, Inc. (CVSI) (OTCQB:CVSI) (the "Company", "CV Sciences", "our", "us" or "we"), a preeminent consumer wellness ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results